Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes.

Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes.

Item
http://www.wikidata.org/entity/Q33301654
Action of Nanoparticles on Platelet Activation and Plasmatic CoagulationAntiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo.In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer.Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors.pH-dependent cytotoxic effects of extracts of the marine sponge Polymastia janeirensis on cancer cell lines.Update on taxane development: new analogs and new formulationsMolecular targeting of liposomal nanoparticles to tumor microenvironment.Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.Nanopreparations to overcome multidrug resistance in cancer.No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer.Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860

Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes.

Item
http://www.wikidata.org/entity/Q33301654
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@ast
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@en
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@nl
type
label
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@ast
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@en
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@nl
prefLabel
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@ast
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@en
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Tumor-selective vessel occlusi ...... sulated in cationic liposomes.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921